WHO World Antimicrobial Resistance Awareness Week starts today:

Research from Chalmers University of Technology, Sweden, shows that resistant bacteria can regain susceptibility to antibiotics when the treatment is combined with a material equipped with antibacterial peptides. The study, performed in a laboratory environment, shows that antibiotics can achieve a 64-fold increase in bactericidal effect when used together with the material, whose antibacterial properties are also greatly enhanced by this combination.

The bactericidal material has been developed for medical applications and has been studied by the researchers for many years. It has shown a strong ability to kill many different types of bacteria – including antibiotic-resistant ones. The material consists of a specially designed hydrogel that contains antibacterial peptides, which are molecules that also serve as the building blocks of proteins.

To enable clinical use for the peptide material, particularly in combination with standard treatments such as antibiotics, the researchers had to ensure that the material does not negatively impact the effectiveness of antibiotics when used concurrently.

The study yielded surprisingly positive results: the antibiotics contrariwise became more effective in combination with the material. The researchers also discovered a synergistic effect against certain resistant bacteria, where the antibacterial effects of the peptide material and antibiotics were not only additive but greatly enhanced when used together. This has not been demonstrated before.

"When particles of the hydrogel came into close contact with the bacteria, they weakened and became more susceptible to the antibiotic treatment. In some cases, the antibiotics became effective again against bacteria that were previously resistant," says Annija Stepulane, doctoral student in applied chemistry at Chalmers and the first author of the scientific paper.

Resistant bacteria regained susceptibility
The peptide material was tested in bacterial cultures, in combination with two different antibiotics: oxacillin and vancomycin. The bacteria included in the experiments were two types of staphylococci (S. aureus), one of which is a strain resistant to several antibiotics (MRSA).

The most powerful effect observed in the study was with MRSA, especially when the material was combined with oxacillin – an antibiotic to which the bacteria are normally resistant. The combination lowered the effective concentration of oxacillin 64-fold compared to when the antibiotic was used alone. Consequently, the concentration of oxacillin fell below the threshold at which the bacteria are classified as resistant to the drug.

With vancomycin, the effective concentration was also lowered when the drug was combined with the hydrogel, though this effect was additive rather than synergistic.

Stable and active treatment over time
Researchers have tried to combine antimicrobial peptides with antibiotics previously, but so far only with peptides in solution. In this form, the peptides are highly sensitive and lose effectiveness when exposed to bodily fluids, such as blood. However, when the peptides are attached to a hydrogel, they become significantly more stable and can be active for a longer period.

The Chalmers researchers have previously measured bactericidal activity lasting for several days with the hydrogel, as opposed to a few hours with peptides in solution. They see numerous advantages with this formulation.

"The peptide-based material can be applied locally, on a limited part of the body, so that the entire body is not affected. The material is non-toxic and does not cause any adverse side effects," says Martin Andersson, research leader and professor of applied chemistry at Chalmers.

May curb infections and reduce the risk of complications
The hydrogel, which can also be formulated as particles in a spray, can increase the safety and efficacy of a course of antibiotics that the patient receives. One potential application of this discovery is in wound treatment.

"Often, you don't know whether the bacteria that caused a wound infection are resistant to a certain antibiotic when you start treatment. Applying the peptide material to the wound simultaneously increases the likelihood of the antibiotic being effective against the bacteria. Then you can cure the infection without having to use additional types of antibiotics," says Martin Andersson.

Since the peptide material only has a positive impact on the healing process, the researchers also see great advantages in using it as a standard treatment to prevent wound infections.

"The material could be used in healthcare settings, for example following surgeries – a possibility already available for veterinary care in some countries – and at home. It could function like a regular band-aid, especially for those concerned about infections. This can be particularly interesting in areas with a high prevalence of resistant infections, such as certain parts of Africa and Asia, where extra caution is needed with wound injuries," says Martin Andersson.


More about: the research results and the peptide material
Antimicrobial peptides exist naturally in our bodies and their strong bactericidal properties have been known for a long time. The bacterial cells die because the peptides damage their cell membranes, primarily through an interaction between positive charges in the peptides and negative charges in the bacterial membranes.

Synergistic effects between peptides and antibiotics have been shown previously, but only with free peptides in solution, which are challenging to work with clinically because they break down quickly. The current study is the first to show efficacy with peptides which are bound to a material, making them stable enough for clinical application.

The Chalmers researchers have previously shown that 99.99 percent of skin bacteria are killed by the material and that the bactericidal efficacy is active for more than two days. This enables using the material in many different products, such as wound care materials and coatings on medical devices that are used within the body.

The researchers have theories about the causes of the synergistic effect with antibiotics, but the molecular mechanisms remain to be explored.


More about: research and product development
Research on the antibacterial material is being carried out in close collaboration with the spin-off company Amferia, which is working to commercialize the findings from Chalmers University of Technology.

During this autumn, a wound care dressing with the hydrogel is launched in eight different European countries, intended for veterinary use. An application for approval for a wound care dressing for humans has been submitted for the US market, and the researchers anticipate that it will be available there within a year. The introduction to the European market will take slightly more time due to differing regulations.

The paper Antibacterial efficacy of antimicrobial peptide-functionalized hydrogel particles combined with vancomycin and oxacillin antibiotics has been published in the scientific journal International Journal of Pharmaceutics. The study has been conducted by Annija Stepulane (Chalmers University of Technology), Anand Kumar Rajasekharan (Amferia) and Martin Andersson (Chalmers University of Technology and Amferia).

Annija Stepulane will defend her PhD thesis Soft Amphiphilic Biomaterials for Antibacterial Applications at Chalmers 12 December.

Read more about the research:
Martin Andersson was recently awarded the Chalmers Impact Award 2024

Previous press releases:
New spray fights infections and antibiotic resistance
New material to treat wounds can protect against resistant bacteria

WHO World Antimicrobial Resistance Awareness Week
Today, Monday 18 November, the World Health Organization (WHO) begins its annual campaign week to raise awareness and understanding of a serious threat to global public health – antibiotic resistance. World AMR Awareness Week is a global campaign held every year between 18 and 24 November to increase awareness and understanding of antimicrobial resistance, AMR.